DrugPatentWatch Database Preview
EMPLICITI Drug Profile
» See Plans and Pricing
Summary for Tradename: EMPLICITI
| Patents: | 24 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for EMPLICITI |
Recent Clinical Trials for EMPLICITI
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Fate Therapeutics | Phase 1 |
| Multiple Myeloma Research Consortium | Phase 1/Phase 2 |
| Bristol-Myers Squibb | Phase 1/Phase 2 |
Pharmacology for EMPLICITI
| Ingredient-type | Antibodies, Monoclonal |
| Mechanism of Action | SLAMF7-directed Antibody Interactions |
Patent Text Search: US Patents for EMPLICITI
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | EMPLICITI | elotuzumab | INJECTABLE;INJECTION | 761035 | 001 | 2015-11-30 | Start Trial | KANGPU BIOPHARMACEUTICALS, LTD. (Shanghai, CN) | 2034-10-30 | RX | Orphan | search |
| Bristol Myers Squibb | EMPLICITI | elotuzumab | INJECTABLE;INJECTION | 761035 | 001 | 2015-11-30 | Start Trial | Celgene Corporation (Summit, NJ) | 2039-02-26 | RX | Orphan | search |
| Bristol Myers Squibb | EMPLICITI | elotuzumab | INJECTABLE;INJECTION | 761035 | 001 | 2015-11-30 | Start Trial | AbbVie Stemcentrx LLC (North Chicago, IL) | 2033-02-08 | RX | Orphan | search |
| Bristol Myers Squibb | EMPLICITI | elotuzumab | INJECTABLE;INJECTION | 761035 | 001 | 2015-11-30 | Start Trial | Advenchen Pharmaceuticals, LLC (Moorpark, CA) | 2035-05-04 | RX | Orphan | search |
| Bristol Myers Squibb | EMPLICITI | elotuzumab | INJECTABLE;INJECTION | 761035 | 001 | 2015-11-30 | Start Trial | CureVac AG (Tubingen, DE) | 2032-02-15 | RX | Orphan | search |
| Bristol Myers Squibb | EMPLICITI | elotuzumab | INJECTABLE;INJECTION | 761035 | 001 | 2015-11-30 | Start Trial | Purdue Pharmaceutical Products L.P. (Stamford, CT) | 2039-02-26 | RX | Orphan | search |
| Bristol Myers Squibb | EMPLICITI | elotuzumab | INJECTABLE;INJECTION | 761035 | 001 | 2015-11-30 | Start Trial | Cipla Limited (Mumbai, IN) | 2036-06-30 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for EMPLICITI
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2014160336 | Start Trial |
| Australia | 2013214204 | Start Trial |
| Japan | 2018517415 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2017189679 | Start Trial |
| Hong Kong | 1212354 | Start Trial |
| Japan | 2019147800 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2014124326 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
